Insmed, Inc. (INSM) Reports Q3 Loss of $1.39, Sales Fall Y/Y
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $107.58 +2.71%
Revenue Growth %: +264.2%
Financial Fact:
Income tax expense: 25K
Today's EPS Names:
DTGI, CRMT, STZ, More
Revenue Growth %: +264.2%
Financial Fact:
Income tax expense: 25K
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q3 EPS of ($1.39), versus ($0.03) reported last year. Revenue for the quarter came in at $400 thousand, versus $1.8 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Palvella Therapeutics adds Matt Pauls to its board of directors
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
